Evaluation of carcinogenicity following intratesticular transplantation of autologous bone marrow-derived mesenchymal stem cells in non-obstructive azoospermia patients: a retrospective analysis
Open Access
- 24 December 2025
- journal article
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (4) , 14330
Abstract
Background: Non-obstructive azoospermia (NOA) cases may have severely deficient spermatogenesis and inadequate sperm production. Despite increasing clinical investigations emphasizing the safety of mesenchymal stem cell (MSC) therapy in NOA cases, no article has recently reviewed the adverse events and carcinogenicity after transplantation. Objective: the study was conducted to evaluate the safety and potential carcinogenic effects of autologous human bone marrow- MSCs implanted into the testes of patients with NOA. Methods: This retrospective cohort study was conducted throughout the period from January2017 to January 2022, encompassed 100 patients aged 20-40 years with primary infertility, with NOA for at least 2 years duration who had a confirmed diagnosis of NOA, based on two separate semen analyses showing azoospermia with centrifugation, conducted at least three months apart. Patients were submitted to intratesticular transplantation of autologous bone marrow-derived mesenchymal stem cells. Records of all participants were examined to acquire the demographic data of patients, laboratory investigations including β-HCG, ECG, AFP, LDH, and scrotal ultrasound examination. Results: there is no significant malignancy or cancer occurrence post- MSCs therapy as indicated by the normal level of the tumor marker levels for LDH (183.4 ± 31.5) u/L, AFP (3.16 ± 1.6) ng/ ml, CEA (2.27 ± 1.1) ng/ ml, and β-HCG (0.95 ± 0.2) mIU/mL. Additionally, scrotal ultrasound showed no focal findings in all cases. Conclusions: there is no carcinogenic effect of mesenchymal stem cells implanted into testes.Keywords
This publication has 25 references indexed in Scilit:
- Biomarkers in Testicular CancerUrologic Clinics of North America, 2022
- Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male InfertilityEuropean Urology, 2021
- Current updates and future perspectives in the evaluation of azoospermia: A systematic reviewArab Journal of Urology, 2021
- Predictors of surgical sperm retrieval in non-obstructive azoospermia: summary of current literatureInternational Urology and Nephrology, 2020
- Infertility in women with systemic autoimmune diseasesBest Practice & Research Clinical Endocrinology & Metabolism, 2019
- Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guidelineCytotherapy, 2018
- The present and future of serum diagnostic tests for testicular germ cell tumoursNature Reviews Urology, 2016
- Multipotent Mesenchymal Stromal Cell Therapy and Risk of MalignanciesStem Cell Reviews and Reports, 2012
- The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical studyLeukemia, 2008